Chimeric Antigen Receptor Natural Killer Cells for the Treatment of Patients With B-Cell Malignancies

H&O What are the outcomes associated with chimeric antigen receptor (CAR) T-cell therapy in patients with non-Hodgkin lymphoma (NHL) or chronic lymphocytic leukemia (CLL)? KR […]

Highlights in B-Cell Malignancies From the 61st American Society of Hematology Annual Meeting

Ibrutinib and Rituximab Provides Superior Clinical Outcome Compared to FCR in Younger Patients With Chronic Lymphocytic Leukemia: Extended Follow-Up From the E1912 Trial Chemoimmunotherapy consisting of […]